
Sun Pharmaceutical Industries Limited has informed the Exchange about press release dated 18-May-2022 titled launching of Brillo, a first-in-class oral lipid-lowering drug in India.
Filed with NSE ·

Sun Pharmaceutical Industries Limited has informed the Exchange about press release dated 18-May-2022 titled launching of Brillo, a first-in-class oral lipid-lowering drug in India.
6ix hasn’t read this filing yet.
Sun Pharmaceutical Industries Limited on 6ix
Follow Sun Pharmaceutical Industries into a list and get an email when it puts out news.
Follow Sun Pharmaceutical Industries